ImmunityBio, Inc. — Director's Dealing 2015

Nov 20, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2015-11-13

Reporting Person: Wilson Angela (Chief Financial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Units	$		Common Stock (35000)		Direct

Footnotes

F1: Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, the restricted stock units ("RSUs") will vest as follows: 50% of the RSUs will vest on November 10, 2017, and 50% of the RSUs will vest on November 10, 2019.

F2: Each restricted stock unit represents a contingent right to receive one share of NantKwest, Inc. common stock.